Diverse small molecules prevent macrophage lysis during pyroptosis

Area of Science:

• Cellular biology
• Immunology
• Pharmacology

Background:

• Pyroptosis is a programmed inflammatory cell death pathway involving caspase-1 and gasdermin D, leading to cell lysis and release of inflammatory mediators.
• Pyroptosis is implicated in various inflammatory diseases, including sepsis, where it contributes to lethality.
• Glycine is known to prevent pyroptotic lysis, but the underlying mechanism remains unclear.

Purpose of the Study:

• To investigate small molecules structurally related to glycine for their ability to prevent pyroptotic lysis.
• To elucidate the mechanism by which glycine and related molecules inhibit pyroptosis.
• To identify novel therapeutic strategies for pyroptosis-driven inflammatory diseases.

Main Methods:

• Systematic screening of glycine analogs for pyroptotic lysis inhibition.
• Genetic analysis using Glrb mutant macrophages to assess the role of glycine receptors.
• Electrophysiological studies to evaluate chloride channel activity.
• Small-molecule screening to identify novel ion channel modulators.

Main Results:

• Structural analysis revealed that the carboxyl group is essential for pyroptotic lysis inhibition by glycine analogs.
• The glycine receptor and chloride channel activity are not required for pyroptotic cytoprotection.
• Novel ion channel modulators were identified that inhibit pyroptotic lysis more potently than glycine.

Conclusions:

• Pyroptotic lysis can be pharmacologically modulated by small molecules.
• The cytoprotective effects of glycine against pyroptosis are independent of the glycine receptor and chloride channels.
• This research opens avenues for developing new therapies targeting pyroptosis in inflammatory diseases.